<DOC>
	<DOCNO>NCT01093963</DOCNO>
	<brief_summary>The specific aim study evaluate efficacy tolerability stimulant ( lisdexamfetamine ) adjunctive treatment bipolar disorder .</brief_summary>
	<brief_title>Efficacy Study Lisdexamfetamine Treat Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Men woman , age 18 55 year , inclusive . Women pregnant , lactating , childbearing potential use adequate contraceptive measure . Subjects display clinically significant homicidality suicidality Clinically unstable medical disease , include cardiovascular , hepatic , renal , gastrointestinal , pulmonary , metabolic , endocrine systemic disease . Subjects biochemically euthyroid enter study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>